Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 23.00
+0.30 (1.32%)
Aug 21, 2026, 5:35 PM CET
EPA:BLC Market Cap
EPA:BLC has a market cap or net worth of €170.48 million as of August 21, 2026. Its market cap has decreased by -15.70% in one year.
Market Cap
170.48M
Enterprise Value
468.83M
Revenue
510.46M
Ranking
n/a
PE Ratio
19.03
Stock Price
€23.00
ChartMarket Cap Chart
Since May 22, 1997, EPA:BLC's market cap has increased from 10.73M to 170.48M, an increase of 1,488.64%. That is a compound annual growth rate of 9.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 170.48M | -2.83% |
| Dec 31, 2025 | 175.44M | -0.18% |
| Dec 31, 2024 | 175.75M | -10.17% |
| Dec 29, 2023 | 195.66M | -27.00% |
| Dec 30, 2022 | 268.04M | -18.51% |
| Dec 31, 2021 | 328.91M | -11.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 94.58B |
| EssilorLuxottica Société anonyme | 75.01B |
| Sartorius Stedim Biotech | 18.83B |
| Ipsen | 13.40B |
| Transgene | 221.30M |
| Cellectis | 208.64M |
| Eurobio Scientific Société anonyme | 200.36M |
| Innate Pharma | 179.20M |